Latest Financial Results Title Date Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update Nov 14, 2022 Latest Form 10-Q Filing year - Any -202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000 Form Filing date View 10-Q Nov 14, 2022 View HTML 0001113148-22-000022.pdf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Latest Annual Report and 10-K 10-K 2021 Annual Report Latest Proxy Statement Filing year - Any -202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000 Form Filing date View DEF 14A Apr 25, 2022 View HTML 0001140361-22-015673.pdf Share Related Items Market Capitalization (Mil) $57.18 Shares Outstanding (Mil) 89.35 Shares Outstanding, Average (FY) (Mil) 85.60 Float (Mil) 88.23
Latest Financial Results Title Date Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update Nov 14, 2022 Latest Form 10-Q Filing year - Any -202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000 Form Filing date View 10-Q Nov 14, 2022 View HTML 0001113148-22-000022.pdf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Latest Annual Report and 10-K 10-K 2021 Annual Report Latest Proxy Statement Filing year - Any -202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000 Form Filing date View DEF 14A Apr 25, 2022 View HTML 0001140361-22-015673.pdf Share Related Items Market Capitalization (Mil) $57.18 Shares Outstanding (Mil) 89.35 Shares Outstanding, Average (FY) (Mil) 85.60 Float (Mil) 88.23
